This is further reinforced by the observation showingthat glioma C6 cells treated with the COX-2 inhibitor, NS398, generate a CM low in PGE2and VEGF that increases TEER to values above those obtained with astrocyte CM. The gene discussed is VEGFA; the disease is central nervous system cancer.